Adjuvant Therapy With PD1/PDL1 Inhibitors for Human Cancers: A Systematic Review and Meta-Analysis

Adjuvant Therapy With PD1/PDL1 Inhibitors for Human Cancers: A Systematic Review and Meta-Analysis

BackgroundImmune checkpoint inhibitors (ICIs) have made a breakthrough in the systemic treatment of patients with advanced tumors. However, little is known about their efficacy and safety in adjuvant settings after the resection of solid tumors.MethodsWe performed a meta-analysis on the efficacy and...

Full description

Bibliographic Details
Main Authors: Yao Jin, Jiayan Wei, Yiming Weng, Jia Feng, Zexi Xu, Peiwei Wang, Xue Cui, Xinyi Chen, Jinsong Wang, Min Peng
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-02-01
Series:Frontiers in Oncology
Subjects:
human cancers
immune checkpoint inhibitor
PD1
PDL1
adjuvant therapy
meta-analysis
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.732814/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.732814/full

Similar Items